Atlas Trials

Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

Clinical trial NCT01736189 · COMPLETED

Trial details

NCT number
NCT01736189
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2012-10-11
Primary completion
2018-04-16
Enrollment
346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.